| Application no. and date | 20757034.2 (espacenet) (Federated) (European Patent Register), 20200724 | | Patent/reg. no. and date | DK/EP 4003400, 20240403 | | Publication date | 20220601 | | Priority no. and date | US 201962879306 P, 20190726, US 202062976321 P, 20200213 | | EP pub. no. and date |
EP 4003400 20220601 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | | Applicant ref. no. | | | Inventor | KALO, Matthew, 1 DNA Way
South San Francisco, CA 94080-4990, US,
SUKUMARAN, Siddharth, 1 DNA Way
South San Francisco, CA 94080-4990, US,
WANG, Yehong, 1 DNA Way
South San Francisco, CA 94080-4990, US,
LU, Timothy Then-Chioh, 1 DNA Way
South San Francisco, CA 94080-4990, US,
PECK, Melicent Clare, 1 DNA Way
South San Francisco, CA 94080-4990, US,
WONG, Chin Yat, 1 DNA Way
South San Francisco, CA 94080-4990, US,
DAY, Peter William, 1 DNA Way
South San Francisco, CA 94080-4990, US | | Representative | | | Opponent | | | IPC Class | A61K 38/20 (2006.01) , A61P 37/06 (2006.01) , C07K 14/54 (2006.01) , C07K 19/00 (2006.01) | | Title | DOSING FOR PREVENTION OR TREATMENT OF GRAFT VERSUS HOST DISEASE (GVHD) WITH IL-22 FC FUSION PROTEINS | | Int. application no. | US2020043542 | | Int. publication no. | WO2021021647 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
